Michael Lee

Expert Consensus on the Use of Teprotumumab for the Management of Thyroid Eye Disease Using a Modified-Delphi Approach

R. Perry, Jeremy C K Tan, Shoaib Ugradar, 2022, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

Convalescent Plasma for COVID-19: A Single Center Prospective Experience with Serial Antibody Measurements and Review of the Literature

P. Duerksen-Hughes, M. Reeves, V. Filippov, 2022, Pathogens.

TNF-α inhibitor tanfanercept (HBM9036) improves signs and symptoms of dry eye in a phase 2 trial in the controlled adverse environment in China

G. Ousler, Xiaoxiang Chen, Dongfang Li, 2022, International Ophthalmology.

Batoclimab as an add‐on therapy in neuromyelitis optica spectrum disorder patients with acute attacks

Yu Peng, Yuge Wang, Honghao Wang, 2022, European journal of neurology.

Therapeutic Effects of Batoclimab in Chinese Patients with Generalized Myasthenia Gravis: A Double-Blinded, Randomized, Placebo-Controlled Phase II Study

Hao Zhou, Han Yang, Yu Chen, 2022, Neurology and Therapy.

Therapeutic Response and Possible Biomarkers in Acute Attacks of Neuromyelitis Optica Spectrum Disorders: A Prospective Observational Study

Y. Long, Yuge Wang, Yaxin Lu, 2021, Frontiers in Immunology.